LT3463281T - Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos - Google Patents

Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos

Info

Publication number
LT3463281T
LT3463281T LTEPPCT/EP2017/025157T LTEP2017025157T LT3463281T LT 3463281 T LT3463281 T LT 3463281T LT EP2017025157 T LTEP2017025157 T LT EP2017025157T LT 3463281 T LT3463281 T LT 3463281T
Authority
LT
Lithuania
Prior art keywords
peptidomimetics
hairpin
beta
elastic
dosage forms
Prior art date
Application number
LTEPPCT/EP2017/025157T
Other languages
English (en)
Inventor
Piet BRUIJNZEEL
Johann Zimmermann
Philip BARTH
Eric Chevalier
Christian Ludin
Manfred Keller
Original Assignee
Spexis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spexis Ag filed Critical Spexis Ag
Publication of LT3463281T publication Critical patent/LT3463281T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
LTEPPCT/EP2017/025157T 2016-05-31 2017-05-31 Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos LT3463281T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31
PCT/EP2017/025157 WO2017207118A1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

Publications (1)

Publication Number Publication Date
LT3463281T true LT3463281T (lt) 2022-09-26

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2017/025157T LT3463281T (lt) 2016-05-31 2017-05-31 Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos
LTEPPCT/EP2017/025156T LT3463280T (lt) 2016-05-31 2017-05-31 Beta plaukų segtuko struktūros peptido mimetikas, pasižymintis elastazės slopiklio aktyvumu ir jo aerozolinės vaisto formos

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2017/025156T LT3463280T (lt) 2016-05-31 2017-05-31 Beta plaukų segtuko struktūros peptido mimetikas, pasižymintis elastazės slopiklio aktyvumu ir jo aerozolinės vaisto formos

Country Status (27)

Country Link
US (3) US11235024B2 (lt)
EP (2) EP3463280B1 (lt)
JP (4) JP7544466B2 (lt)
KR (2) KR102511284B1 (lt)
CN (3) CN109195580A (lt)
AU (2) AU2017273508B2 (lt)
BR (2) BR112018074551B1 (lt)
CA (2) CA3024522C (lt)
CL (2) CL2018003390A1 (lt)
DK (2) DK3463280T3 (lt)
EA (2) EA039603B1 (lt)
ES (2) ES2927948T3 (lt)
HR (2) HRP20221194T1 (lt)
HU (2) HUE060119T2 (lt)
IL (2) IL263114B2 (lt)
LT (2) LT3463281T (lt)
MA (2) MA45168A (lt)
MX (2) MX2018014425A (lt)
PH (2) PH12018502521A1 (lt)
PL (2) PL3463280T3 (lt)
PT (2) PT3463281T (lt)
RS (2) RS63639B1 (lt)
SG (3) SG10202113280XA (lt)
SM (2) SMT202200404T1 (lt)
UA (2) UA125900C2 (lt)
WO (2) WO2017207117A1 (lt)
ZA (2) ZA201807772B (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE060119T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái
CA3151997A1 (en) * 2019-08-23 2021-03-04 Ph Pharma Co., Ltd. Use of a neutrophil elastase inhibitor in lung disease
KR20220133227A (ko) * 2020-01-30 2022-10-04 버텍스 파마슈티칼스 인코포레이티드 알파-1 항트립신 결핍증의 치료 방법
CN115697969B (zh) 2020-04-03 2026-08-11 弗特克斯药品有限公司 α-1抗胰蛋白酶调节剂
AU2021247285A1 (en) 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
JP7732999B2 (ja) 2020-04-03 2025-09-02 バーテックス ファーマシューティカルズ インコーポレイテッド アルファ１－アンチトリプシンのモジュレーター
EP4188931A2 (en) 2020-07-27 2023-06-07 Vertex Pharmaceuticals Incorporated Processes for preparing modulators of alpha-1 antitrypsin
KR20230123950A (ko) * 2020-11-23 2023-08-24 스펙시스 아게 베타-헤어핀 펩티도미메틱의 조성물 및 이의 에어로졸 투여 형태
CN116782879A (zh) * 2020-11-23 2023-09-19 斯佩希斯股份公司 β-发夹素拟肽的组合物及其气雾剂剂型
CN116421704A (zh) * 2023-02-20 2023-07-14 成都佩德生物医药有限公司 多肽pd-dp-005在制备治疗肺部疾病药物中的应用及其药物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1304118A3 (en) * 1996-11-01 2004-01-14 XOMA Technology Ltd. Therapeutic uses and formulations for BPI protein products.
AU2006206272A1 (en) 2005-01-21 2006-07-27 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
EP1856140B1 (en) * 2005-02-17 2013-12-25 Polyphor Ltd. Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
RU2433841C2 (ru) * 2006-02-09 2011-11-20 Пари Фарма Гмбх Доставка в легкие альфа-1-ингибитора протеиназ
JP2009526003A (ja) * 2006-02-10 2009-07-16 パーリ・ファルマ・ゲーエムベーハー 吸入療法用噴霧状抗生物質
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
EP2567691B1 (en) * 2011-09-12 2014-12-24 Meiji Seika Pharma Co., Ltd. Aqueous compositions comprising arbekacin
US9453829B2 (en) 2013-12-23 2016-09-27 Shijiazhuang Tiedao University Soil property test device
US10340848B2 (en) 2013-12-26 2019-07-02 Kaneka Corporation I-V measurement device for solar cell, manufacturing method for solar cell, and solar cell module
LT3087094T (lt) 2013-12-27 2022-09-26 Spexis Ag Beta plaukų segtuko struktūros peptidų mimetikai, kaip selektyvūs elastazės slopikliai
JP6499182B2 (ja) * 2013-12-27 2019-04-10 ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ 選択的エラスターゼ阻害剤としてのβ−ヘアピンペプチド模倣体
HUE060119T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái

Also Published As

Publication number Publication date
US20220023379A1 (en) 2022-01-27
UA125899C2 (uk) 2022-07-06
SMT202200404T1 (it) 2022-11-18
ZA201807772B (en) 2022-10-26
ZA201807773B (en) 2022-07-27
CA3024522C (en) 2024-06-25
RS63622B1 (sr) 2022-10-31
AU2017273507B2 (en) 2022-03-17
JP7286319B6 (ja) 2023-06-16
CN109195580A (zh) 2019-01-11
LT3463280T (lt) 2022-09-26
DK3463281T3 (da) 2022-09-26
UA125900C2 (uk) 2022-07-06
IL263114A (en) 2018-12-31
PL3463280T3 (pl) 2022-11-07
HRP20221194T1 (hr) 2022-12-09
IL263112B1 (en) 2023-06-01
PT3463281T (pt) 2022-10-07
ES2927948T3 (es) 2022-11-14
CA3024521A1 (en) 2017-12-07
MX2018014752A (es) 2019-04-25
MA45167A (fr) 2019-04-10
EP3463281B1 (en) 2022-07-06
IL263114B1 (en) 2023-08-01
US11235023B2 (en) 2022-02-01
MX2018014425A (es) 2019-03-28
JP2022078013A (ja) 2022-05-24
IL263112B2 (en) 2023-10-01
RS63639B1 (sr) 2022-10-31
EP3463281A1 (en) 2019-04-10
PL3463281T3 (pl) 2022-11-07
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
JP7286319B2 (ja) 2023-06-05
JP7544466B2 (ja) 2024-09-03
MA45168A (fr) 2019-04-10
KR20190015309A (ko) 2019-02-13
ES2928050T3 (es) 2022-11-15
AU2017273508A1 (en) 2018-12-13
CN116159024A (zh) 2023-05-26
CA3024521C (en) 2023-06-20
BR112018074532A2 (pt) 2019-03-19
PT3463280T (pt) 2022-10-07
CN109310613A (zh) 2019-02-05
JP2023017793A (ja) 2023-02-07
PH12018502522A1 (en) 2019-10-21
EA039603B1 (ru) 2022-02-16
EP3463280B1 (en) 2022-07-06
HUE060119T2 (hu) 2023-02-28
SG11201810138XA (en) 2018-12-28
US11844823B2 (en) 2023-12-19
DK3463280T3 (da) 2022-09-26
EA201892819A1 (ru) 2019-05-31
BR112018074551B1 (pt) 2022-02-08
JP2019523222A (ja) 2019-08-22
PH12018502521A1 (en) 2019-10-21
KR102480800B1 (ko) 2022-12-22
SG10202113280XA (en) 2021-12-30
EA201892818A1 (ru) 2019-05-31
MX393629B (es) 2025-03-24
IL263114B2 (en) 2023-12-01
IL263112A (en) 2018-12-31
KR102511284B1 (ko) 2023-03-16
AU2017273507A1 (en) 2018-12-13
US20200230203A1 (en) 2020-07-23
HRP20221185T1 (hr) 2022-12-09
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
SG11201810137UA (en) 2018-12-28
US11235024B2 (en) 2022-02-01
CA3024522A1 (en) 2017-12-07
BR112018074551A2 (pt) 2019-03-06
AU2017273508B2 (en) 2022-07-28
BR112018074532B1 (pt) 2022-02-08
EP3463280A1 (en) 2019-04-10
CL2018003391A1 (es) 2019-05-03
HUE060393T2 (hu) 2023-02-28
SMT202200405T1 (it) 2022-11-18
CL2018003390A1 (es) 2019-05-03
JP2019523763A (ja) 2019-08-29

Similar Documents

Publication Publication Date Title
EP3649616C0 (en) REAL-TIME POSITION AND ORIENTATION TRACKING DEVICE
HRP20260186T1 (hr) Inkretinski analozi i njihova upotreba
HRP20260151T1 (hr) Modificirani polipeptidi i njihova uporaba
PL3516243T3 (pl) Samowiercący i samozagłębiający element złączny
LT3256218T (lt) Kdm1a inhibitorius ir jo panaudojimas terapijoje
EP3228626A4 (en) Peptide having activity to improve skin condition and use thereof
EP3114217A4 (en) Caspase polypeptides having modified activity and uses thereof
LT2989088T (lt) Dolastatino 10 ir auristatinų dariniai
ZA201807772B (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
LT3394065T (lt) Tetrahidropiranilamino-pirolopirimidinonas ir jo panaudojimo būdai
PL3426244T3 (pl) Inhibitory dehydrogenazy 3-fosfoglicerynianowej i ich zastosowania
IL292869A (en) Compositions having pesticidal utility and processes related thereto
DK3292145T3 (da) Fc-mutanter med modificeret funktionel aktivitet
IL291217A (en) Usp30 inhibitors and uses thereof
IL270577B1 (en) Plant extracts with anti-diabetic and other useful activities
EP3708488C0 (en) ROTARY DEVICE AND AIRCRAFT
EP3524833C0 (en) Anti-loosening threaded pair and anti-loosening threaded section
PL3720875T3 (pl) Peptydy przeciwdrobnoustrojowe i sposoby ich stosowania
DK3555279T3 (da) Polypeptider med endoglucanase-aktivitet og anvendelser deraf
SI3678692T1 (sl) Stratifikacija genotipa pri zdravljenju in preprečevanju sladkorne bolezni
EP3638102C0 (en) DETECTION OF ACTIVITY IN PERIPHERAL NERVE
DK3481865T5 (da) Fc-mutanter med forbedret funktionel aktivitet
DK3464579T3 (da) Sammensætninger omfattende polypeptider med galactanaseaktivitet og polypeptider med betagalactosidaseaktivitet
KR102135648B9 (ko) 항독성 또는 항병원성 활성을 갖는 레오이딘 화합물 및 이의 용도
ZA201807471B (en) Variant polypeptides with improved performance and use of the same